PDUFAin 119d
Aquestive Therapeutics, Inc. — Anaphylm (dibutepinephrine)
FDA PDUFA goal date for Class 2 resubmission of Anaphylm sublingual film NDA.
- Date
- Mar 16, 2027
- Type
- PDUFA
- Ticker
- AQST
- Indication
- Severe allergies / anaphylaxis
PDUFAin 119d
FDA PDUFA goal date for Class 2 resubmission of Anaphylm sublingual film NDA.
The weekly brief is free. Pro adds reminders 7 days and 1 day before.